Company Overview
American HealthCare Capital is pleased to exclusively represent a nutritional supplement company for sale. This research-based company develops, manufactures, and sells nutritional supplements using proprietary amino acid formulations to support immune function and overall health. The Company operates semi-virtually, utilizing contractors and collaborators for product development and manufacturing.
Product and Research
The Company’s first product is a proprietary nutritional supplement formulation combining vitamins and amino acids in a convenient melt-away tablet form. According to the Company, laboratory and clinical studies have evaluated the formulation, including a double-blind, placebo-controlled clinical trial that demonstrated safety and potential benefits in supporting immune health. The product is currently available on Amazon. Supporting research can be made available to interested buyers for independent review.
Intellectual Property
According to the Company, its formulation and other products in development are covered by a portfolio of patents granted in the USA and international markets. The Company also has a pending patent application relating to the potential antiviral applications of its proprietary formulation. The current status and remaining terms of patent protection are subject to confirmation.
Market and Growth Opportunity
The company believes there is potential for growth through increased brand awareness and expansion into practitioners, pharmacies, wellness clinics, Med-spas, and other channels.
Financial Summary
While the company continues to operate at a loss, it has invested in developing, validating, and manufacturing novel supplement formulations for over 10 years but has not had sufficient capital to market its final products effectively. The product has achieved minimal sales.
Asking Price
The price and structure are to be determined based on buyer due diligence and negotiations. Potential terms may include an upfront payment, milestone-based payments, and royalties on future sales.